Bethel Nutritional Consulting, Inc, is voluntarily recalling 1 lot of both SLIM-K Capsules and B-Lipo Capsules due to undeclared drug ingredients in each product.
Bethel Nutritional Consulting, Inc, is voluntarily recalling 1 lot of both SLIM-K Capsules and B-Lipo Capsules due to undeclared drug ingredients in each product, according to the FDA.
The recall was initiated after the FDA collected and tested samples of both products, which are marketed as natural herbal supplements for weight loss. The sample of SLIM-K was found to contain sibutramine, desmethylsibutramine, and phenolphthalein, while the sample of B-Lipo was found to contain lorcaserin.
The affected lot of SLIM-K is lot number 140430 and the affected lot of B-Lipo is 20213.
Bethel has advised patients not to consume the products and to return them to the place of purchase. Consumers with questions regarding this recall should contact Bethel by phone at 212-568-5330 or by e-mail at email@example.com.
In addition to contacting their health care providers, patients who have experienced adverse reactions to the products should report them to the FDA’s MedWatch Adverse Event Reporting program. Patients can submit the form online at www.fda.gov/medwatch/report.htm, download it at www.fda.gov/MedWatch/getforms.htm, or call 1-800-332-1088 to request it. Completed paper forms can be returned to the address on the pre-addressed form or faxed to 1-800-FDA-0178.